In its third quarter results of 2024, pharmaceutical giant GSK confirmed it would pay a quarterly dividend of 15 pence. However, Morningstar analyst Christopher Johnson says he believes that GSK’s ...
Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. Read More on GB:GSK: GSK NewsMORE Related Stocks Indices ...
He’s openly criticized the FDA and has called for an end to the regulatory oversight of many health products, including ...
Despite pressure on consumer spending, consumers prioritise trusted brands for their health-related needs and Haleon is a ...
GSK’s Arexvy has received expanded approval in Canada for preventing RSV-related lower respiratory tract disease in adults ...
GlobalData on MSN5d
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...
The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...
With an array of new medicines and medical devices on display global medical companies are looking to tap further into the ...
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Nigeria, the giant of Africa, has recently experienced a great downturn in its economy, leading to the exodus of several ...
LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...
The winner will be announced Wednesday evening at The American Lawyer's Industry Awards. These attorneys have been named ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback